FDA Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
Title:
FDA Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
Origin/Publisher:
FDA
Content:
This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products.